• Issue

    Diabetes/Metabolism Research and Reviews: Volume 23, Issue 4

    253-336, i-ix
    May/June 2007
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

In this Issues

Free Access

In this issue

  • Pages: 253-254
  • First Published: 02 May 2007

Editorials

Immuno-intervention and preservation of beta-cell function in type 1 diabetes

Paolo Pozzilli, 
  • Pages: 255-256
  • First Published: 02 May 2007

Review Articles

When basal insulin therapy in type 2 diabetes mellitus is not enough—what next?

Denis Raccah,  Reinhard G Bretzel,  David Owens,  Matthew Riddle, 
  • Pages: 257-264
  • First Published: 21 February 2007

U-500 insulin: why, when and how to use in clinical practice

R. Garg,  V. Johnston,  P. G. McNally,  M. J. Davies,  I. G. Lawrence, 
  • Pages: 265-268
  • First Published: 16 November 2006

Research Articles

Therapy with the hsp60 peptide DiaPep277™ in C-peptide positive type 1 diabetes patients†

Volkert A. L. Huurman,  Katelijn Decochez,  Chantal Mathieu,  Irun R. Cohen,  Bart O. Roep, 
  • Pages: 269-275
  • First Published: 06 October 2006

Effect of heat shock protein peptide DiaPep277 on ß-cell function in paediatric and adult patients with recent-onset diabetes mellitus type 1: two prospective, randomized, double-blind phase II trials

Nanette C. Schloot,  Guido Meierhoff,  Csaba Lengyel,  Gyözö Vándorfi,  József Takács,  Pál Pánczél,  László Barkai,  László Madácsy,  Tamás Oroszlán,  Peter Kovács,  Gábor Sütö,  Tadej Battelino,  Nora Hosszufalusi,  György Jermendy, 
  • Pages: 276-285
  • First Published: 14 November 2006

Heat-shock protein peptide DiaPep277 treatment in children with newly diagnosed type 1 diabetes: a randomised, double-blind phase II study

L. Lazar,  R. Ofan,  N. Weintrob,  A. Avron,  M. Tamir,  D. Elias,  M. Phillip,  Z. Josefsberg, 
  • Pages: 286-291
  • First Published: 24 November 2006

Treatment of new-onset type 1 diabetes with peptide DiaPep277® is safe and associated with preserved beta-cell function: extension of a randomized, double-blind, phase II trial

I. Raz,  A. Avron,  M. Tamir,  M. Metzger,  L. Symer,  R. Eldor,  I. R. Cohen,  D. Elias, 
  • Pages: 292-298
  • First Published: 24 November 2006

Metformin prolongs the postprandial fall in plasma ghrelin concentrations in type 2 diabetes

P. J. English,  A. Ashcroft,  M. Patterson,  T. M. Dovey,  J. C. G. Halford,  J. Harrison,  D. Eccleston,  S. R. Bloom,  M. A. Ghatei,  J. P. H. Wilding, 
  • Pages: 299-303
  • First Published: 04 September 2006

Acute insulin response is an independent predictor of type 2 diabetes mellitus in individuals with both normal fasting and 2-h plasma glucose concentrations†

Joy C. Bunt,  Jonathan Krakoff,  Emilio Ortega,  William C. Knowler,  Clifton Bogardus, 
  • Pages: 304-310
  • First Published: 25 September 2006

Decline of neuroadrenergic bronchial innervation and respiratory function in type 1 diabetes mellitus: a longitudinal study

Raffaele Antonelli Incalzi,  Leonello Fuso,  Dario Pitocco,  Salvatore Basso,  Andrea Trové,  Anna Longobardi,  Maria Lucia Calcagni,  Alessandro Giordano,  Giovanni Ghirlanda, 
  • Pages: 311-316
  • First Published: 02 October 2006

High glucose activates pituitary proopiomelanocortin gene expression: possible role of free radical-sensitive transcription factors

Koichi Asaba,  Yasumasa Iwasaki,  Masato Asai,  Masanori Yoshida,  Takeshi Nigawara,  Machiko Kambayashi,  Kozo Hashimoto, 
  • Pages: 317-323
  • First Published: 21 August 2006

Prolonged exposure to homocysteine results in diminished but reversible pancreatic β-cell responsiveness to insulinotropic agents

Steven Patterson,  Siobhan M. J. Scullion,  Jane T. McCluskey,  Peter R. Flatt,  Neville H. McClenaghan, 
  • Pages: 324-334
  • First Published: 06 November 2006

Conference Calendars

Conference calendar

  • Pages: 335-336
  • First Published: 02 May 2007

Current Awareness

Current literature in diabetes

  • Pages: i-ix
  • First Published: 02 May 2007